Improvement in the placebo group could be due to regression to the mean as well as to sociobiologic factors

被引:7
作者
Rück, A [1 ]
Sylvén, C [1 ]
机构
[1] Karolinska Inst, Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden
关键词
D O I
10.1016/j.amjcard.2005.08.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:152 / +
页数:2
相关论文
共 4 条
[1]  
Galton F., 1886, The Journal of the Anthropological Institute of Great Britain and Ireland, V15, P246, DOI [10.2307/2841583, DOI 10.2307/2841583]
[2]   Direct intramyocardial plasmid vascular endothelial growth factor-A165-gene therapy in patients with stable severe angina pectoris -: A randomized double-blind placebo-controlled study:: The Euroinject One trial [J].
Kastrup, J ;
Jorgensen, E ;
Rück, A ;
Tägil, K ;
Glogar, D ;
Ruzyllo, W ;
Botker, HE ;
Dudek, D ;
Drvota, V ;
Hesse, B ;
Thuesen, L ;
Blomberg, P ;
Gyöngyösi, M ;
Sylvén, C .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (07) :982-988
[3]   Regression to the mean: treatment effect without the intervention [J].
Morton, V ;
Torgerson, DJ .
JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2005, 11 (01) :59-65
[4]   Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease [J].
Rana, JS ;
Mannam, A ;
Donnell-Fink, L ;
Gervino, EV ;
Sellke, FW ;
Laham, RJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (12) :1456-1459